Today’s news
Eli Lilly's New Weight Loss Drug Sees High Dropout Rates
Participants taking the highest dose of retatrutide lost an average of 28.7% of their body weight, but some dropped out due to excessive weight loss.
Participants Drop Out of Eli Lilly's New Weight Loss Drug Trial Due to Excessive Weight Loss
The experimental 'Triple G' drug retatrutide led to an average 28.7% weight loss, but some participants left the study over concerns about becoming too slim.
New Scale May Capture Emotional Burden of Obesity
The Weight and Emotions Scale (WES) aims to assess how obesity or overweight, and their treatment, affect patients' emotional well-being.
